Clinical trial of minimally invasive laminoplasty for cervical spondylotic myelopathy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002536

Enrollment

Unknown

Registered

2012-09-08

Start date

2010-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylotic myelopathy

Interventions

Group C:traditional posterior approach of cervical spine operation

Group A:minimally invasive laminoplasty using microendoscopy

Group B:minimally invasive laminoplasty

Eligibility

Sex/Gender

All

Age

39 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of cervical spondylotic myelopathy; 2. Confirmed surgical indications of posterior approach of cervical spine operation accordance with the criteria published by Chinese Medical Association; 3. The informed consent document has been signed.

Exclusion criteria

Exclusion criteria: 1. Accompany With posterior approach of cervical spine operation accordance with the criteria published by Chinese Medical Association; 2. Unable to complete research questionnaires; 3. Rejecting to randomization.

Design outcomes

Primary

Measure	Time frame
JOA score;SF-36 score;axial symptom;cervical curvature index,CCI;range of motion, RO;	—

Countries

China

Contacts

Public ContactChunlin Zhang

zzclin@126.com+86 13903835325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026